Register now for the NCCN 2022 Annual Congress: Hematologic Malignancies™ to access high-quality educational content, networking opportunities, and more!
Dates: Friday, October 14, 2022 – Saturday, October 15, 2022
Location: New York Marriott Marquis | New York, New York
Attendance options: Attend either in-person in New York or remotely through a virtual event platform. All attendees will have full access to:
Those attending in-person will have additional networking opportunities, including a Welcome Reception on Friday evening. Those attending onsite will also receive complimentary breakfast, lunch, and refreshments during breaks.
This 1.5-day, CE-certified event will focus on the latest advances in hematologic malignancies. Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, the program will feature panel discussions with world-renowned experts, interactive presentations, and challenging patient cases that highlight recent updates to the NCCN Guidelines®, new and emerging therapeutic agents, and practical management strategies for patients with hematologic malignancies.
This year’s agenda includes 18 on-demand and live educational sessions designed to meet the educational needs of oncologists, hematologists, nurse practitioners, nurses, pharmacists, physician assistants, and other health care professionals who manage patients with hematologic malignancies. This program is approved for AMA PRA Category 1 Credit™ and ABIM, ABPath, and ABMS MOC for physicians and is also certified for credit for nurses, pharmacists, and other oncology professionals.
Agenda topics include:
|
|
For CE program supporter opportunities, contact Lisa Perfidio, Senior Manager, CE Supporter Outreach.
This program is supported by an independent medical education grant from Jazz Pharmaceuticals.
This activity is supported by educational funding provided by Amgen.
This activity is supported by a medical education grant from Karyopharm Therapeutics.
Visit the NCCN Exhibition Hall in-person and virtually for networking opportunities and to gather the latest information from industry-sponsored exhibits, the Patient Advocacy Pavilion, and more.
For exhibitor opportunities, contact Jennifer Tredwell, Vice President, Marketing and Communications
NCCN 2022 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™
Saturday, October 15, 2022
New York, New York
Registration is separate from the NCCN Hematologic Malignancies Congress. Virtual attendance option available.
Topics Include:
Accreditation
This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.
Supporters
Takeda
This activity is supported by independent medical education grants from:
Pharmacyclics LLC and Janssen and Jazz Pharmaceuticals
Recorded Presentations from the NCCN 2021 Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ are now available.
Save the dates!
NCCN 2023 Annual Congress: Hematologic Malignancies™